This report aims to provide a comprehensive presentation of the global market for Genome Sequencing, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genome Sequencing.

The Genome Sequencing market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genome Sequencing market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genome Sequencing manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Genome Sequencing market size in 2022 is 16716.60 million US dollars, and it is expected to be 47817.94 million US dollars by 2029, with a compound annual growth rate of 16.20% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Genome Sequencing market include Abbott (U.S.), BioMérieux (France), B.D. (U.S.), Danaher (U.S., and Thermo Fisher Scientific Inc., (U.S.). The share of the top 3 players in the Genome Sequencing market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, in which North America accounted for XX%, Europe accounted for XX% of Genome Sequencing market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Consumables accounted for XX% of Genome Sequencing market in 2022. Systems and Software share of XX%.
Diagnostics accounted for XX% of the Genome Sequencing market in 2022. Drug Discovery and Development accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Genome Sequencing market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the Genome Sequencing industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 4-6: Segmented the global Genome Sequencing market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-10: Provide Americas, Europe, Asia-Pacific and Middle East & Africa Genome Sequencing market country segmentation data.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 12-14: Provide detailed Genome Sequencing market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: The main points and conclusions of the report.
Chapter 16: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey

Player list
Abbott (U.S.)
BioMérieux (France)
B.D. (U.S.)
Danaher (U.S.
Thermo Fisher Scientific Inc., (U.S.)
Siemens (Germany)
Agilent Technologies, Inc, (U.S.)
Merck KGaA (Germany)
Illumina Inc. (U.S.)
QIAGEN (Germany)
Bio-Rad Laboratories, Inc. (U.S.)
Eurofins Scientific (Luxembourg)
Danaher (U.S.)
Oxford Nanopore Technologies plc (U.K.).
F. Hoffmann-La Roche Ltd (Switzerland)
BGI (U.S.), General Electric (U.S.)
LI-COR, Inc (U.S.).
Siemens (U.S.)
PerkinElmer, Inc. (U.S.).
Macrogen, Inc (South Korea)
BIONEER CORPORATION (South Korea)

Types list
Consumables
Systems and Software
Services

Application list
Diagnostics
Drug Discovery and Development
Precision Medicine
Construction and Agriculture and Animal Research
Others

Table of Content

1 Study Coverage
1.1 Genome Sequencing Product Introduction
1.2 Market by Type
1.2.1 Global Genome Sequencing Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Genome Sequencing Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Genome Sequencing Market by Region
1.4.1 Global Genome Sequencing Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Genome Sequencing Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Genome Sequencing Revenue by Players
2.1.1 Global Genome Sequencing Revenue by Players (2018-2023)
2.1.2 Global Genome Sequencing Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Genome Sequencing Revenue in 2023
2.2 Global Genome Sequencing Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Genome Sequencing Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Abbott (U.S.)
3.1.1 Abbott (U.S.) Information
3.1.2 Abbott (U.S.) Overview
3.1.3 Abbott (U.S.) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.1.4 Abbott (U.S.) Related Developments
3.2 BioMérieux (France)
3.2.1 BioMérieux (France) Information
3.2.2 BioMérieux (France) Overview
3.2.3 BioMérieux (France) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.2.4 BioMérieux (France) Related Developments
3.3 B.D. (U.S.)
3.3.1 B.D. (U.S.) Information
3.3.2 B.D. (U.S.) Overview
3.3.3 B.D. (U.S.) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.3.4 B.D. (U.S.) Related Developments
3.4 Danaher (U.S.
3.4.1 Danaher (U.S. Information
3.4.2 Danaher (U.S. Overview
3.4.3 Danaher (U.S. Genome Sequencing Revenue and Gross Margin (2018-2023)
3.4.4 Danaher (U.S. Related Developments
3.5 Thermo Fisher Scientific Inc., (U.S.)
3.5.1 Thermo Fisher Scientific Inc., (U.S.) Information
3.5.2 Thermo Fisher Scientific Inc., (U.S.) Overview
3.5.3 Thermo Fisher Scientific Inc., (U.S.) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.5.4 Thermo Fisher Scientific Inc., (U.S.) Related Developments
3.6 Siemens (Germany)
3.6.1 Siemens (Germany) Information
3.6.2 Siemens (Germany) Overview
3.6.3 Siemens (Germany) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.6.4 Siemens (Germany) Related Developments
3.7 Agilent Technologies, Inc, (U.S.)
3.7.1 Agilent Technologies, Inc, (U.S.) Information
3.7.2 Agilent Technologies, Inc, (U.S.) Overview
3.7.3 Agilent Technologies, Inc, (U.S.) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.7.4 Agilent Technologies, Inc, (U.S.) Related Developments
3.8 Merck KGaA (Germany)
3.8.1 Merck KGaA (Germany) Information
3.8.2 Merck KGaA (Germany) Overview
3.8.3 Merck KGaA (Germany) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.8.4 Merck KGaA (Germany) Related Developments
3.9 Illumina Inc. (U.S.)
3.9.1 Illumina Inc. (U.S.) Information
3.9.2 Illumina Inc. (U.S.) Overview
3.9.3 Illumina Inc. (U.S.) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.9.4 Illumina Inc. (U.S.) Related Developments
3.10 QIAGEN (Germany)
3.10.1 QIAGEN (Germany) Information
3.10.2 QIAGEN (Germany) Overview
3.10.3 QIAGEN (Germany) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.10.4 QIAGEN (Germany) Related Developments
3.11 Bio-Rad Laboratories, Inc. (U.S.)
3.11.1 Bio-Rad Laboratories, Inc. (U.S.) Information
3.11.2 Bio-Rad Laboratories, Inc. (U.S.) Overview
3.11.3 Bio-Rad Laboratories, Inc. (U.S.) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.11.4 Bio-Rad Laboratories, Inc. (U.S.) Related Developments
3.12 Eurofins Scientific (Luxembourg)
3.12.1 Eurofins Scientific (Luxembourg) Information
3.12.2 Eurofins Scientific (Luxembourg) Overview
3.12.3 Eurofins Scientific (Luxembourg) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.12.4 Eurofins Scientific (Luxembourg) Related Developments
3.13 Danaher (U.S.)
3.13.1 Danaher (U.S.) Information
3.13.2 Danaher (U.S.) Overview
3.13.3 Danaher (U.S.) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.13.4 Danaher (U.S.) Related Developments
3.14 Oxford Nanopore Technologies plc (U.K.).
3.14.1 Oxford Nanopore Technologies plc (U.K.). Information
3.14.2 Oxford Nanopore Technologies plc (U.K.). Overview
3.14.3 Oxford Nanopore Technologies plc (U.K.). Genome Sequencing Revenue and Gross Margin (2018-2023)
3.14.4 Oxford Nanopore Technologies plc (U.K.). Related Developments
3.15 F. Hoffmann-La Roche Ltd (Switzerland)
3.15.1 F. Hoffmann-La Roche Ltd (Switzerland) Information
3.15.2 F. Hoffmann-La Roche Ltd (Switzerland) Overview
3.15.3 F. Hoffmann-La Roche Ltd (Switzerland) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.15.4 F. Hoffmann-La Roche Ltd (Switzerland) Related Developments
3.16 BGI (U.S.), General Electric (U.S.)
3.16.1 BGI (U.S.), General Electric (U.S.) Information
3.16.2 BGI (U.S.), General Electric (U.S.) Overview
3.16.3 BGI (U.S.), General Electric (U.S.) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.16.4 BGI (U.S.), General Electric (U.S.) Related Developments
3.17 LI-COR, Inc (U.S.).
3.17.1 LI-COR, Inc (U.S.). Information
3.17.2 LI-COR, Inc (U.S.). Overview
3.17.3 LI-COR, Inc (U.S.). Genome Sequencing Revenue and Gross Margin (2018-2023)
3.17.4 LI-COR, Inc (U.S.). Related Developments
3.18 Siemens (U.S.)
3.18.1 Siemens (U.S.) Information
3.18.2 Siemens (U.S.) Overview
3.18.3 Siemens (U.S.) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.18.4 Siemens (U.S.) Related Developments
3.19 PerkinElmer, Inc. (U.S.).
3.19.1 PerkinElmer, Inc. (U.S.). Information
3.19.2 PerkinElmer, Inc. (U.S.). Overview
3.19.3 PerkinElmer, Inc. (U.S.). Genome Sequencing Revenue and Gross Margin (2018-2023)
3.19.4 PerkinElmer, Inc. (U.S.). Related Developments
3.20 Macrogen, Inc (South Korea)
3.20.1 Macrogen, Inc (South Korea) Information
3.20.2 Macrogen, Inc (South Korea) Overview
3.20.3 Macrogen, Inc (South Korea) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.20.4 Macrogen, Inc (South Korea) Related Developments
3.21 BIONEER CORPORATION (South Korea)
3.21.1 BIONEER CORPORATION (South Korea) Information
3.21.2 BIONEER CORPORATION (South Korea) Overview
3.21.3 BIONEER CORPORATION (South Korea) Genome Sequencing Revenue and Gross Margin (2018-2023)
3.21.4 BIONEER CORPORATION (South Korea) Related Developments
4 Market Size by Type
4.1 Global Genome Sequencing Revenue by Type
4.2 Global Genome Sequencing Market Size Growth by Type 2018-2023
5 Market Size by Application
5.1 Global Genome Sequencing Revenue by Application
5.2 Global Genome Sequencing Market Size Growth by Application 2018-2023
6 Global Genome Sequencing Market Insights
6.1 Global Genome Sequencing Market Revenue 2018-2023
6.2 Global Genome Sequencing Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Genome Sequencing Market Size by Country
7.1.1 Americas Genome Sequencing Revenue by Country (2018-2023)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Genome Sequencing Market Size by Country
8.1.1 Europe Genome Sequencing Revenue by Country (2018-2023)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Genome Sequencing Market Size by Region
9.1.1 Asia Pacific Genome Sequencing Revenue by Region (2018-2023)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Genome Sequencing Market Size by Country
10.1.1 Middle East and Africa Genome Sequencing Revenue by Country (2018-2023)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Genome Sequencing Industry Trends
11.2 Genome Sequencing Market Drivers
11.3 Genome Sequencing Market Challenges
11.4 Genome Sequencing Market Restraints
12 Genome Sequencing Forecasted Market Size by Type
12.1 Global Genome Sequencing Forecasted Revenue by Type
12.2 Global Genome Sequencing Forecasted Market Size Growth by Type 2023-2029
13 Genome Sequencing Forecasted Market Size by Application
13.1 Global Genome Sequencing Forecasted Revenue by Application
13.2 Global Genome Sequencing Forecasted Market Size Growth by Application 2023-2029
14 Global Genome Sequencing Market Forecasts
14.1 Global Genome Sequencing Market Revenue Forecasts 2023-2029
14.2 Global Genome Sequencing Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer

List of Tables and Figures

Figure Genome Sequencing Picture
Table Product Definition of Genome Sequencing
Table Global Genome Sequencing Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
Table Global Genome Sequencing Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
Table Global Genome Sequencing Market by Region: 2018 VS 2023 VS 2029
Figure Global Genome Sequencing Revenue Market Size & Forecasts 2018-2029
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Genome Sequencing Revenue by Players (2018-2023)
Table Global Genome Sequencing Revenue Market Share by Players (2018-2023)
Figure Top 5 Largest Players of Genome Sequencing in 2023
Figure Top 10 Largest Players of Genome Sequencing in 2023
Table Global Genome Sequencing Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global Genome Sequencing Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Abbott (U.S.) Overview
Table Abbott (U.S.) Revenue, Gross, Gross Margin 2018-2023
Table Abbott (U.S.) Related Developments
Table Company Profiles
Table BioMérieux (France) Overview
Table BioMérieux (France) Revenue, Gross, Gross Margin 2018-2023
Table BioMérieux (France) Related Developments
Table Company Profiles
Table B.D. (U.S.) Overview
Table B.D. (U.S.) Revenue, Gross, Gross Margin 2018-2023
Table B.D. (U.S.) Related Developments
Table Company Profiles
Table Danaher (U.S. Overview
Table Danaher (U.S. Revenue, Gross, Gross Margin 2018-2023
Table Danaher (U.S. Related Developments
Table Company Profiles
Table Thermo Fisher Scientific Inc., (U.S.) Overview
Table Thermo Fisher Scientific Inc., (U.S.) Revenue, Gross, Gross Margin 2018-2023
Table Thermo Fisher Scientific Inc., (U.S.) Related Developments
Table Company Profiles
Table Siemens (Germany) Overview
Table Siemens (Germany) Revenue, Gross, Gross Margin 2018-2023
Table Siemens (Germany) Related Developments
Table Company Profiles
Table Agilent Technologies, Inc, (U.S.) Overview
Table Agilent Technologies, Inc, (U.S.) Revenue, Gross, Gross Margin 2018-2023
Table Agilent Technologies, Inc, (U.S.) Related Developments
Table Company Profiles
Table Merck KGaA (Germany) Overview
Table Merck KGaA (Germany) Revenue, Gross, Gross Margin 2018-2023
Table Merck KGaA (Germany) Related Developments
Table Company Profiles
Table Illumina Inc. (U.S.) Overview
Table Illumina Inc. (U.S.) Revenue, Gross, Gross Margin 2018-2023
Table Illumina Inc. (U.S.) Related Developments
Table Company Profiles
Table QIAGEN (Germany) Overview
Table QIAGEN (Germany) Revenue, Gross, Gross Margin 2018-2023
Table QIAGEN (Germany) Related Developments
Table Company Profiles
Table Bio-Rad Laboratories, Inc. (U.S.) Overview
Table Bio-Rad Laboratories, Inc. (U.S.) Revenue, Gross, Gross Margin 2018-2023
Table Bio-Rad Laboratories, Inc. (U.S.) Related Developments
Table Company Profiles
Table Eurofins Scientific (Luxembourg) Overview
Table Eurofins Scientific (Luxembourg) Revenue, Gross, Gross Margin 2018-2023
Table Eurofins Scientific (Luxembourg) Related Developments
Table Company Profiles
Table Danaher (U.S.) Overview
Table Danaher (U.S.) Revenue, Gross, Gross Margin 2018-2023
Table Danaher (U.S.) Related Developments
Table Company Profiles
Table Oxford Nanopore Technologies plc (U.K.). Overview
Table Oxford Nanopore Technologies plc (U.K.). Revenue, Gross, Gross Margin 2018-2023
Table Oxford Nanopore Technologies plc (U.K.). Related Developments
Table Company Profiles
Table F. Hoffmann-La Roche Ltd (Switzerland) Overview
Table F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Gross, Gross Margin 2018-2023
Table F. Hoffmann-La Roche Ltd (Switzerland) Related Developments
Table Company Profiles
Table BGI (U.S.), General Electric (U.S.) Overview
Table BGI (U.S.), General Electric (U.S.) Revenue, Gross, Gross Margin 2018-2023
Table BGI (U.S.), General Electric (U.S.) Related Developments
Table Company Profiles
Table LI-COR, Inc (U.S.). Overview
Table LI-COR, Inc (U.S.). Revenue, Gross, Gross Margin 2018-2023
Table LI-COR, Inc (U.S.). Related Developments
Table Company Profiles
Table Siemens (U.S.) Overview
Table Siemens (U.S.) Revenue, Gross, Gross Margin 2018-2023
Table Siemens (U.S.) Related Developments
Table Company Profiles
Table PerkinElmer, Inc. (U.S.). Overview
Table PerkinElmer, Inc. (U.S.). Revenue, Gross, Gross Margin 2018-2023
Table PerkinElmer, Inc. (U.S.). Related Developments
Table Company Profiles
Table Macrogen, Inc (South Korea) Overview
Table Macrogen, Inc (South Korea) Revenue, Gross, Gross Margin 2018-2023
Table Macrogen, Inc (South Korea) Related Developments
Table Company Profiles
Table BIONEER CORPORATION (South Korea) Overview
Table BIONEER CORPORATION (South Korea) Revenue, Gross, Gross Margin 2018-2023
Table BIONEER CORPORATION (South Korea) Related Developments
Table Global Genome Sequencing Revenue by Type (2018-2023)
Table Global Genome Sequencing Revenue Share by Type (2018-2023)
Table Global Genome Sequencing Revenue by Application (2018-2023)
Table Global Genome Sequencing Revenue Share by Application (2018-2023)
Figure Global Genome Sequencing Market Revenue 2018-2023
Table Global Genome Sequencing Revenue by Region (2018-2023)
Table Global Genome Sequencing Revenue Share by Region (2018-2023)
Figure Americas Genome Sequencing Revenue (2018-2023)
Figure Europe Genome Sequencing Revenue (2018-2023)
Figure Asia-Pacific Genome Sequencing Revenue (2018-2023)
Figure Middle East & Africa Genome Sequencing Revenue (2018-2023)
Table Americas Genome Sequencing Revenue by Country (2018-2023)
Table Americas Genome Sequencing Revenue Share by Country (2018-2023)
Figure United States Genome Sequencing Revenue Market Size (2018-2023)
Figure Canada Genome Sequencing Revenue Market Size (2018-2023)
Figure Mexico Genome Sequencing Revenue Market Size (2018-2023)
Figure Brazil Genome Sequencing Revenue Market Size (2018-2023)
Figure Argentina Genome Sequencing Revenue Market Size (2018-2023)
Table Europe Genome Sequencing Revenue by Country (2018-2023)
Table Europe Genome Sequencing Revenue Share by Country (2018-2023)
Figure Germany Genome Sequencing Revenue Market Size (2018-2023)
Figure France Genome Sequencing Revenue Market Size (2018-2023)
Figure U.K. Genome Sequencing Revenue Market Size (2018-2023)
Figure Italy Genome Sequencing Revenue Market Size (2018-2023)
Figure Russia Genome Sequencing Revenue Market Size (2018-2023)
Table Asia Pacific Genome Sequencing Revenue by Region (2018-2023)
Table Asia Pacific Genome Sequencing Revenue Share by Region (2018-2023)
Figure China Genome Sequencing Revenue Market Size (2018-2023)
Figure Japan Genome Sequencing Revenue Market Size (2018-2023)
Figure South Korea Genome Sequencing Revenue Market Size (2018-2023)
Figure India Genome Sequencing Revenue Market Size (2018-2023)
Figure Southeast Asia Genome Sequencing Revenue Market Size (2018-2023)
Figure Australia Genome Sequencing Revenue Market Size (2018-2023)
Table Middle East and Africa Genome Sequencing Revenue by Country (2018-2023)
Table Middle East and Africa Genome Sequencing Revenue Share by Country (2018-2023)
Figure Turkey Genome Sequencing Revenue Market Size (2018-2023)
Figure Saudi Arabia Genome Sequencing Revenue Market Size (2018-2023)
Figure U.A.E Genome Sequencing Revenue Market Size (2018-2023)
Table Global Genome Sequencing Forecasted Revenue by Type (2018-2023)
Table Global Genome Sequencing Forecasted Revenue Share by Type (2018-2023)
Table Global Genome Sequencing Forecasted Revenue by Application (2018-2023)
Table Global Genome Sequencing Forecasted Revenue Share by Application (2018-2023)
Figure Global Genome Sequencing Market Revenue Forecasts 2023-2029
Table Global Genome Sequencing Forecasts Revenue by Region (2023-2029)
Table Global Genome Sequencing Forecasts Revenue Share by Region (2023-2029)
Figure Americas Genome Sequencing Forecasts Revenue and Growth (2023-2029)
Figure Europe Genome Sequencing Forecasts Revenue and Growth (2023-2029)
Figure Asia-Pacific Genome Sequencing Forecasts Revenue and Growth (2023-2029)
Figure Middle East & Africa Genome Sequencing Forecasts Revenue and Growth (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report